124 related articles for article (PubMed ID: 21422883)
1. ACOG Committee Opinion No. 486: Update on carrier screening for cystic fibrosis.
Obstet Gynecol; 2011 Apr; 117(4):1028-1031. PubMed ID: 21422883
[TBL] [Abstract][Full Text] [Related]
2. Patterns of preconception, prenatal and postnatal care for diabetic women by obstetrician-gynecologists.
Power ML; Wilson EK; Hogan SO; Loft JD; Williams JL; Mersereau PW; Schulkin J
J Reprod Med; 2013; 58(1-2):7-14. PubMed ID: 23447912
[TBL] [Abstract][Full Text] [Related]
3. Commercially Available Prenatal Vitamins Do Not Meet American College of Obstetricians and Gynecologists Nutritional Guidelines.
Cai F; Young BK; Mccoy JA
Am J Perinatol; 2024 May; 41(S 01):e2547-e2554. PubMed ID: 37419140
[TBL] [Abstract][Full Text] [Related]
4. Reproductive genetic carrier screening in pregnancy: improving health outcomes and expanding access.
Mei JY; Platt LD
J Perinat Med; 2024 Jun; ():. PubMed ID: 38924780
[TBL] [Abstract][Full Text] [Related]
5. Improvement of interpretation in cystic fibrosis clinical laboratory reports: longitudinal analysis of external quality assessment data.
Berwouts S; Girodon E; Schwarz M; Stuhrmann M; Morris MA; Dequeker E
Eur J Hum Genet; 2012 Dec; 20(12):1209-15. PubMed ID: 22713805
[TBL] [Abstract][Full Text] [Related]
6. Bayesian analysis and risk assessment in genetic counseling and testing.
Ogino S; Wilson RB
J Mol Diagn; 2004 Feb; 6(1):1-9. PubMed ID: 14736820
[TBL] [Abstract][Full Text] [Related]
7. Responsible implementation of expanded carrier screening.
Henneman L; Borry P; Chokoshvili D; Cornel MC; van El CG; Forzano F; Hall A; Howard HC; Janssens S; Kayserili H; Lakeman P; Lucassen A; Metcalfe SA; Vidmar L; de Wert G; Dondorp WJ; Peterlin B
Eur J Hum Genet; 2016 Jun; 24(6):e1-e12. PubMed ID: 26980105
[TBL] [Abstract][Full Text] [Related]
8. Preconception care: call for national guidelines.
Bialystok L; Poole N; Greaves L
Can Fam Physician; 2013 Oct; 59(10):1037-9, e435-7. PubMed ID: 24130271
[No Abstract] [Full Text] [Related]
9. ACMG position statement on prenatal/preconception expanded carrier screening.
Grody WW; Thompson BH; Gregg AR; Bean LH; Monaghan KG; Schneider A; Lebo RV
Genet Med; 2013 Jun; 15(6):482-3. PubMed ID: 23619275
[TBL] [Abstract][Full Text] [Related]
10. Expanded carrier screening in reproductive medicine-points to consider: a joint statement of the American College of Medical Genetics and Genomics, American College of Obstetricians and Gynecologists, National Society of Genetic Counselors, Perinatal Quality Foundation, and Society for Maternal-Fetal Medicine.
Edwards JG; Feldman G; Goldberg J; Gregg AR; Norton ME; Rose NC; Schneider A; Stoll K; Wapner R; Watson MS
Obstet Gynecol; 2015 Mar; 125(3):653-662. PubMed ID: 25730230
[TBL] [Abstract][Full Text] [Related]
11. Committee Opinion No. 691: Carrier Screening for Genetic Conditions.
Obstet Gynecol; 2017 Mar; 129(3):e41-e55. PubMed ID: 28225426
[TBL] [Abstract][Full Text] [Related]
12. Autosomal Recessive Inheritance: Cystic Fibrosis.
Goldstein DY; Prystowsky M
Acad Pathol; 2017; 4():2374289517691769. PubMed ID: 28815197
[TBL] [Abstract][Full Text] [Related]
13. ACOG committee opinion no. 557: Management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women.
Obstet Gynecol; 2013 Apr; 121(4):891-896. PubMed ID: 23635706
[TBL] [Abstract][Full Text] [Related]
14. Implementation and utilization of genetic testing in personalized medicine.
Abul-Husn NS; Owusu Obeng A; Sanderson SC; Gottesman O; Scott SA
Pharmgenomics Pers Med; 2014; 7():227-40. PubMed ID: 25206309
[TBL] [Abstract][Full Text] [Related]
15. Tay Sachs disease in Australia: reduced disease incidence despite stable carrier frequency in Australian Jews.
Lew RM; Proos AL; Burnett L; Delatycki M; Bankier A; Fietz MJ
Med J Aust; 2012 Dec; 197(11):652-4. PubMed ID: 23230938
[TBL] [Abstract][Full Text] [Related]
16. CFTR variant testing: a technical standard of the American College of Medical Genetics and Genomics (ACMG).
Deignan JL; Astbury C; Cutting GR; Del Gaudio D; Gregg AR; Grody WW; Monaghan KG; Richards S;
Genet Med; 2020 Aug; 22(8):1288-1295. PubMed ID: 32404922
[TBL] [Abstract][Full Text] [Related]
17. Committee Opinion No. 690: Carrier Screening in the Age of Genomic Medicine.
Obstet Gynecol; 2017 Mar; 129(3):e35-e40. PubMed ID: 28225425
[No Abstract] [Full Text] [Related]
18. Clinical utility of expanded carrier screening: results-guided actionability and outcomes.
Johansen Taber KA; Beauchamp KA; Lazarin GA; Muzzey D; Arjunan A; Goldberg JD
Genet Med; 2019 May; 21(5):1041-1048. PubMed ID: 30310157
[TBL] [Abstract][Full Text] [Related]
19. 17-Gene Genomic Prostate Score Test Results in the Canary Prostate Active Surveillance Study (PASS) Cohort.
Lin DW; Zheng Y; McKenney JK; Brown MD; Lu R; Crager M; Boyer H; Tretiakova M; Brooks JD; Dash A; Fabrizio MD; Gleave ME; Kolb S; Liss M; Morgan TM; Thompson IM; Wagner AA; Tsiatis A; Pingitore A; Nelson PS; Newcomb LF
J Clin Oncol; 2020 May; 38(14):1549-1557. PubMed ID: 32130059
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
